Dr. Reddy's Laboratories Ltd. says it would have launched its generic version of Amarin’s Vascepa (icosapent ethyl) in August last year but for the originator’s “illegal conduct to foreclose the supply” of the product’s active pharmaceutical ingredient.
The Indian firm has sued Amarin in a New Jersey district court, alleging violation of the antitrust Sherman Act over...




